Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications

Clustering of insulin resistance and dysmetabolism with obesity is attributed to pathologic adipose tissue. The morphologic hallmarks of this pathology are adipocye hypertrophy and heightened inflammation. However, it's underlying molecular mechanisms remains unknown. Study of gene function in...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandeep Kumar Mathur, Priyanka Jain, Prashant Mathur
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2011/587495
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849684930257223680
author Sandeep Kumar Mathur
Priyanka Jain
Prashant Mathur
author_facet Sandeep Kumar Mathur
Priyanka Jain
Prashant Mathur
author_sort Sandeep Kumar Mathur
collection DOAJ
description Clustering of insulin resistance and dysmetabolism with obesity is attributed to pathologic adipose tissue. The morphologic hallmarks of this pathology are adipocye hypertrophy and heightened inflammation. However, it's underlying molecular mechanisms remains unknown. Study of gene function in metabolically active tissues like adipose tissue, skeletal muscle and liver is a promising strategy. Microarray is a powerful technique of assessment of gene function by measuring transcription of large number of genes in an array. This technique has several potential applications in understanding pathologic adipose tissue. They are: (1) transcriptomic differences between various depots of adipose tissue, adipose tissue from obese versus lean individuals, high insulin resistant versus low insulin resistance, brown versus white adipose tissue, (2) transcriptomic profiles of various stages of adipogenesis, (3) effect of diet, cytokines, adipokines, hormones, environmental toxins and drugs on transcriptomic profiles, (4) influence of adipokines on transcriptomic profiles in skeletal muscle, hepatocyte, adipose tissue etc., and (5) genetics of gene expression. The microarray evidences of molecular basis of obesity and insulin resistance are presented here. Despite the limitations, microarray has potential clinical applications in finding new molecular targets for treatment of insulin resistance and classification of adipose tissue based on future risk of insulin resistance syndrome.
format Article
id doaj-art-bc74e2529066400b97604f4fbfde3740
institution DOAJ
issn 2090-0708
2090-0716
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-bc74e2529066400b97604f4fbfde37402025-08-20T03:23:19ZengWileyJournal of Obesity2090-07082090-07162011-01-01201110.1155/2011/587495587495Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical ImplicationsSandeep Kumar Mathur0Priyanka Jain1Prashant Mathur2Department of Endocrinology, S. M. S. Medical College, IndiaInstitute of Genomics and Integrative Biology, Mall Road, New Delhi 110007, IndiaDepartment of Pharmacology, S. M. S. Medical College, J. L. Marg, Jaipur 302004, IndiaClustering of insulin resistance and dysmetabolism with obesity is attributed to pathologic adipose tissue. The morphologic hallmarks of this pathology are adipocye hypertrophy and heightened inflammation. However, it's underlying molecular mechanisms remains unknown. Study of gene function in metabolically active tissues like adipose tissue, skeletal muscle and liver is a promising strategy. Microarray is a powerful technique of assessment of gene function by measuring transcription of large number of genes in an array. This technique has several potential applications in understanding pathologic adipose tissue. They are: (1) transcriptomic differences between various depots of adipose tissue, adipose tissue from obese versus lean individuals, high insulin resistant versus low insulin resistance, brown versus white adipose tissue, (2) transcriptomic profiles of various stages of adipogenesis, (3) effect of diet, cytokines, adipokines, hormones, environmental toxins and drugs on transcriptomic profiles, (4) influence of adipokines on transcriptomic profiles in skeletal muscle, hepatocyte, adipose tissue etc., and (5) genetics of gene expression. The microarray evidences of molecular basis of obesity and insulin resistance are presented here. Despite the limitations, microarray has potential clinical applications in finding new molecular targets for treatment of insulin resistance and classification of adipose tissue based on future risk of insulin resistance syndrome.http://dx.doi.org/10.1155/2011/587495
spellingShingle Sandeep Kumar Mathur
Priyanka Jain
Prashant Mathur
Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
Journal of Obesity
title Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
title_full Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
title_fullStr Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
title_full_unstemmed Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
title_short Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
title_sort microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications
url http://dx.doi.org/10.1155/2011/587495
work_keys_str_mv AT sandeepkumarmathur microarrayevidencestheroleofpathologicadiposetissueininsulinresistanceandtheirclinicalimplications
AT priyankajain microarrayevidencestheroleofpathologicadiposetissueininsulinresistanceandtheirclinicalimplications
AT prashantmathur microarrayevidencestheroleofpathologicadiposetissueininsulinresistanceandtheirclinicalimplications